{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T06:08:24Z","timestamp":1776406104002,"version":"3.51.2"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00228-026-04040-8","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:43:13Z","timestamp":1774665793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["From empirical caution to precision resumption: model-informed management of a binimetinib overdose in a frail elderly patient"],"prefix":"10.1007","volume":"82","author":[{"given":"Hamza","family":"Sayadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeleen","family":"Fromage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Labriffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Monchaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lo\u00efse","family":"Jourdain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9l\u00e8ne","family":"G\u00e9niaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-0695","authenticated-orcid":false,"given":"Jean-Baptiste","family":"Woillard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"4040_CR1","unstructured":"MEKTOVI (binimetinib) tablets"},{"issue":"5","key":"4040_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/bjc.2017.10","volume":"116","author":"JC Bendell","year":"2017","unstructured":"Bendell JC, Javle M, Bekaii-Saab TS, Finn RS, Wainberg ZA, Laheru DA et al (2017) A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1\/2 inhibitor. Br J Cancer 116(5):575\u2013583. https:\/\/doi.org\/10.1038\/bjc.2017.10","journal-title":"Br J Cancer"},{"issue":"17","key":"4040_CR3","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1200\/JCO.18.02459","volume":"37","author":"E Van Cutsem","year":"2019","unstructured":"Van Cutsem E, Huijberts S, Grothey A, Yaeger R, Cuyle PJ, Elez E et al (2019) Binimetinib, Encorafenib, and Cetuximab triplet therapy for patients with BRAF V600E-mutant metastatic colorectal cancer: safety lead-in results from the phase III BEACON colorectal cancer study. J Clin Oncol 37(17):1460\u20131469.","journal-title":"J Clin Oncol"},{"key":"4040_CR4","unstructured":"ACoP (2024) [Internet] [cited 2025 Dec 12]. Available from: https:\/\/acop2024.eventscribe.net\/fsPopup.asp?efp=T1ZGU0NGRkwyMjQ4Mw&PosterID=690607&mode=posterInfo"},{"issue":"12","key":"4040_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/psp4","volume":"8","author":"A Elmokadem","year":"2019","unstructured":"Elmokadem A, Riggs MM, Baron KT (2019) Quantitative systems pharmacology and physiologically-based pharmacokinetic modeling with mrgsolve: a hands-on tutorial. CPT Pharmacometrics Syst Pharmacol 8(12):883\u2013893. https:\/\/doi.org\/10.1002\/psp4","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"4040_CR6","doi-asserted-by":"crossref","unstructured":"P\u00e9termann YJ, Puszkiel A, Khani A, Kramkimel N, Funck-Brentano E, Oules B et al Population pharmacokinetics of Encorafenib and Binimetinib in real-world BRAFV600E\/K-mutant metastatic melanoma patients in comparison with clinical results [internet]. [cited 2026 Mar 15]. Available from: https:\/\/www.authorea.com\/users\/965977\/articles\/1334487-population-pharmacokinetics-of-encorafenib-and-binimetinib-in-real-world-brafv600e-k-mutant-metastatic-melanoma-patients-in-comparison-with-clinical-results","DOI":"10.22541\/au.175758519.96583383\/v1"},{"issue":"4","key":"4040_CR7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/cpt.2202","volume":"109","author":"SG Wicha","year":"2021","unstructured":"Wicha SG, M\u00e4rtson AG, Nielsen EI, Koch BCP, Friberg LE, Alffenaar JW et al (2021) From therapeutic drug monitoring to model-informed precision dosing for antibiotics. Clin Pharmacol Ther 109(4):928\u2013941. https:\/\/doi.org\/10.1002\/cpt.2202","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"4040_CR8","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1097\/FTD.0000000000001256","volume":"46","author":"H Sayadi","year":"2024","unstructured":"Sayadi H, Fromage Y, Labriffe M, Danthu C, Monchaud C, Woillard JB (2024) Daptomycin dosage optimization in renal impairment using model-informed precision dosing. Ther Drug Monit 46(6):695\u2013698.","journal-title":"Ther Drug Monit"},{"issue":"12","key":"4040_CR9","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1016\/j.ejca.2014.04.015","volume":"50","author":"N Widmer","year":"2014","unstructured":"Widmer N, Bardin C, Chatelut E, Paci A, Beijnen J, Lev\u00eaque D et al (2014) Review of therapeutic drug monitoring of anticancer drugs part two\u2013targeted therapies. Eur J Cancer 50(12):2020\u20132036. https:\/\/doi.org\/10.1016\/j.ejca.2014.04.015","journal-title":"Eur J Cancer"},{"issue":"6","key":"4040_CR10","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/FTD.0000000000001391","volume":"47","author":"MBA van der Kleij","year":"2025","unstructured":"van der Kleij MBA, Groot Beumer KWM, Koolen SLW, Mathijssen RHJ, Steeghs N, Huitema ADR (2025) Therapeutic drug monitoring of oral targeted anticancer drugs: achievements, experiences, challenges, and the path forward. Ther Drug Monit 47(6):713\u2013720.","journal-title":"Ther Drug Monit"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04040-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04040-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T05:37:45Z","timestamp":1776404265000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00228-026-04040-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4040"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04040-8","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"107"}}